Concord Ebitda vs Minority Interest Analysis
CCM Stock | USD 0.67 0.08 13.56% |
Concord Medical financial indicator trend analysis is way more than just evaluating Concord Medical Services prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Concord Medical Services is a good investment. Please check the relationship between Concord Medical Ebitda and its Minority Interest accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Ebitda vs Minority Interest
Ebitda vs Minority Interest Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Concord Medical Services Ebitda account and Minority Interest. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Concord Medical's Ebitda and Minority Interest is -0.41. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Minority Interest in the same time period over historical financial statements of Concord Medical Services, assuming nothing else is changed. The correlation between historical values of Concord Medical's Ebitda and Minority Interest is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Concord Medical Services are associated (or correlated) with its Minority Interest. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Minority Interest has no effect on the direction of Ebitda i.e., Concord Medical's Ebitda and Minority Interest go up and down completely randomly.
Correlation Coefficient | -0.41 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Ebitda
Minority Interest
Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Concord Medical Services whose combined shares represent less than 50% of the total outstanding shares issued by Concord Medical have a minority interest in Concord Medical.Most indicators from Concord Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Concord Medical Services current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. As of the 28th of May 2024, Enterprise Value is likely to grow to about 3.8 B, while Selling General Administrative is likely to drop about 186.8 M.
Concord Medical fundamental ratios Correlations
Click cells to compare fundamentals
Concord Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Concord Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.6B | 4.3B | 5.3B | 6.0B | 6.1B | 4.0B | |
Other Current Liab | 400.7M | 274.7M | 243.2M | 325.2M | 674.1M | 707.8M | |
Total Current Liabilities | 870.3M | 627.5M | 512.1M | 1.1B | 2.0B | 2.0B | |
Total Stockholder Equity | 437.4M | (122.8M) | (663.0M) | (1.9B) | (2.1B) | (2.0B) | |
Other Liab | 287.0M | 270.2M | 230.1M | 268.9M | 309.2M | 324.7M | |
Cash | 404.7M | 74.3M | 334.3M | 158.3M | 58.1M | 55.2M | |
Other Assets | 661.1M | 409.9M | 250.6M | 24.0M | 27.6M | 26.2M | |
Long Term Debt | 1.3B | 2.0B | 2.2B | 2.5B | 2.0B | 2.1B | |
Good Will | 165.2M | 210.4M | 213.7M | 575.4M | 661.7M | 694.8M | |
Common Stock Shares Outstanding | 43.4M | 43.4M | 43.4M | 43.7M | 50.2M | 47.0M | |
Other Current Assets | 5.1M | 4.3M | 31.4M | 24.3M | 412.9M | 433.6M | |
Total Liab | 2.3B | 2.4B | 2.9B | 4.0B | 4.3B | 4.5B | |
Intangible Assets | 895.2M | 532.5M | 522.8M | 762.1M | 721.1M | 425.8M | |
Property Plant Equipment | 2.5B | 3.2B | 3.8B | 3.9B | 4.4B | 4.7B | |
Short Long Term Debt Total | 938.1M | 1.9B | 2.4B | 3.2B | 3.3B | 3.5B | |
Property Plant And Equipment Net | 1.2B | 2.5B | 3.2B | 3.4B | 3.7B | 3.9B | |
Current Deferred Revenue | 23.6M | 3.2M | 87.7M | 100.8M | 59.4M | 32.8M | |
Net Debt | 533.4M | 1.8B | 2.0B | 3.1B | 3.2B | 3.4B | |
Retained Earnings | (1.2B) | (1.8B) | (2.5B) | (3.8B) | (4.1B) | (3.9B) | |
Accounts Payable | 5.4M | 8.3M | 18.6M | 146.7M | 129.2M | 135.7M | |
Non Current Assets Total | 3.4B | 4.0B | 4.7B | 5.2B | 5.4B | 3.2B | |
Non Currrent Assets Other | 4.9M | 661.1M | 107.5M | 23.2M | 6.3M | 6.0M | |
Cash And Short Term Investments | 454.7M | 74.3M | 334.3M | 158.3M | 58.1M | 55.2M | |
Net Receivables | 343.1M | 199.6M | 280.4M | 512.8M | 73.5M | 69.8M | |
Liabilities And Stockholders Equity | 4.6B | 4.3B | 5.3B | 6.0B | 6.1B | 4.2B | |
Non Current Liabilities Total | 1.4B | 1.8B | 2.4B | 2.9B | 2.4B | 1.3B | |
Other Stockholder Equity | 1.8B | 1.8B | 1.8B | 1.9B | 2.0B | 1.6B | |
Property Plant And Equipment Gross | 2.5B | 3.4B | 3.6B | 3.8B | 4.1B | 4.3B | |
Total Current Assets | 1.2B | 282.5M | 676.0M | 759.8M | 617.2M | 741.5M | |
Accumulated Other Comprehensive Income | (88.6M) | (97.3M) | (46.4M) | (27.8M) | (65.4M) | (62.1M) | |
Short Term Debt | 440.6M | 341.3M | 162.5M | 548.5M | 1.1B | 1.1B | |
Short Term Investments | 50M | 35.2M | 25.0M | 2.7M | 2.4M | 2.3M | |
Inventory | 3.4M | 4.3M | 21.6M | 84.8M | 40.3M | 27.4M | |
Net Tangible Assets | (865.7M) | (1.4B) | (2.6B) | (2.8B) | (2.5B) | (2.4B) | |
Long Term Investments | 64.9M | 313.0M | 390.6M | 437.9M | 394.7M | 319.4M | |
Short Long Term Debt | 328.4M | 148.9M | 299.4M | 512.6M | 1.0B | 537.8M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Concord Medical Services using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Concord Stock analysis
When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Revenue Per Share 12.302 | Quarterly Revenue Growth (0.23) | Return On Assets (0.05) | Return On Equity (0.28) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.